PFBT
TRVI icon

Parkside Financial Bank & Trust’s Trevi Therapeutics TRVI Stock Holding History

Parkside Financial Bank & Trust’s Portfolio TRVI Stock Details TRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.67K Hold
140
– – ﹤0.01% 2183
2025
Q4 		$1.75K Hold
140
– – ﹤0.01% 2150
2025
Q3 		$1.28K Hold
140
– – ﹤0.01% 2184
2025
Q2 		$766 Hold
140
– – ﹤0.01% 2350
2025
Q1 		$880 Buy
+140
New +$668 ﹤0.01% 2156

Other funds holding TRVI

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return

Parkside Financial Bank & Trust's TRVI Position: Q1 2026 in Review

Parkside Financial Bank & Trust held its Trevi Therapeutics (TRVI) position steady in Q1 2026 at 140 shares worth $1.67K. The position accounts for ﹤0.01% of the portfolio, ranked #2183.

Parkside Financial Bank & Trust first reported a position in TRVI in Q1 2025 and has held it in 5 quarters since. The position peaked at $1.75K in Q4 2025. 198 funds tracked by Wall St. Rank hold TRVI as of Q1 2026.

  • Parkside Financial Bank & Trust held 140 shares of Trevi Therapeutics worth $1.67K as of Q1 2026.
  • Parkside Financial Bank & Trust left its Trevi Therapeutics share count unchanged in Q1 2026.
  • Trevi Therapeutics made up ﹤0.01% of Parkside Financial Bank & Trust's portfolio in Q1 2026, its #2183 holding.
  • Parkside Financial Bank & Trust first reported a position in Trevi Therapeutics in Q1 2025 and has held it in 5 quarters since.
  • Parkside Financial Bank & Trust's Trevi Therapeutics position peaked at $1.75K in Q4 2025.
  • 198 funds tracked by Wall St. Rank held Trevi Therapeutics as of Q1 2026.

Based on Parkside Financial Bank & Trust's 13F filing for Q1 2026, filed 13 May 2026.